rs111903796

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_183050.4(BCKDHB):​c.742+7A>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000346 in 1,510,058 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 2 hom. )

Consequence

BCKDHB
NM_183050.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00004768
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.879

Publications

0 publications found
Variant links:
Genes affected
BCKDHB (HGNC:987): (branched chain keto acid dehydrogenase E1 subunit beta) This gene encodes the E1 beta subunit of branched-chain keto acid dehydrogenase, which is a multienzyme complex associated with the inner membrane of mitochondria. This enzyme complex functions in the catabolism of branched-chain amino acids. Mutations in this gene have been associated with maple syrup urine disease (MSUD), type 1B, a disease characterized by a maple syrup odor to the urine in addition to mental and physical retardation and feeding problems. Alternative splicing at this locus results in multiple transcript variants. [provided by RefSeq, Jan 2016]
BCKDHB Gene-Disease associations (from GenCC):
  • maple syrup urine disease type 1B
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, G2P, Myriad Women’s Health
  • maple syrup urine disease
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • classic maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermediate maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • intermittent maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • thiamine-responsive maple syrup urine disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 6-80171397-A-T is Benign according to our data. Variant chr6-80171397-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 384206.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00174 (264/151902) while in subpopulation AFR AF = 0.00603 (250/41434). AF 95% confidence interval is 0.00542. There are 1 homozygotes in GnomAd4. There are 137 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BCKDHBNM_183050.4 linkc.742+7A>T splice_region_variant, intron_variant Intron 6 of 9 ENST00000320393.9 NP_898871.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BCKDHBENST00000320393.9 linkc.742+7A>T splice_region_variant, intron_variant Intron 6 of 9 1 NM_183050.4 ENSP00000318351.5
BCKDHBENST00000356489.9 linkc.742+7A>T splice_region_variant, intron_variant Intron 6 of 10 1 ENSP00000348880.5

Frequencies

GnomAD3 genomes
AF:
0.00169
AC:
256
AN:
151782
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00586
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000772
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00240
GnomAD2 exomes
AF:
0.000479
AC:
113
AN:
235840
AF XY:
0.000429
show subpopulations
Gnomad AFR exome
AF:
0.00632
Gnomad AMR exome
AF:
0.000393
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000173
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000377
Gnomad OTH exome
AF:
0.000174
GnomAD4 exome
AF:
0.000190
AC:
258
AN:
1358156
Hom.:
2
Cov.:
21
AF XY:
0.000181
AC XY:
123
AN XY:
680380
show subpopulations
African (AFR)
AF:
0.00617
AC:
192
AN:
31100
American (AMR)
AF:
0.000370
AC:
16
AN:
43258
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25184
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38818
South Asian (SAS)
AF:
0.0000369
AC:
3
AN:
81252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52578
Middle Eastern (MID)
AF:
0.000504
AC:
2
AN:
3968
European-Non Finnish (NFE)
AF:
0.00000683
AC:
7
AN:
1025538
Other (OTH)
AF:
0.000673
AC:
38
AN:
56460
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00174
AC:
264
AN:
151902
Hom.:
1
Cov.:
32
AF XY:
0.00184
AC XY:
137
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.00603
AC:
250
AN:
41434
American (AMR)
AF:
0.000197
AC:
3
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000774
AC:
4
AN:
5166
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10532
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000295
AC:
2
AN:
67910
Other (OTH)
AF:
0.00238
AC:
5
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
14
29
43
58
72
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000603
Hom.:
0
Bravo
AF:
0.00180
Asia WGS
AF:
0.00232
AC:
8
AN:
3466

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Dec 26, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Maple syrup urine disease Benign:1
Nov 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.060
DANN
Benign
0.39
PhyloP100
-0.88
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000048
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111903796; hg19: chr6-80881114; API